Business Standard

Natco Pharma Share Price

Know More
BSENSE

1,561.90-0.30 (-0.02%)

04:01 PM, 17-Sep-2024

1,561.70-16.05 (-1.02%)

03:49 PM, 17-Sep-2024

BSE : 524816

NSE : NATCOPHARM

Sector : Health care

ISIN Code : INE987B01026

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 17-Sep-2024 | 04:01 PM IST

Market Cap (₹ Cr)

27,974

Traded Value (₹ Cr)

1.75

Volume (Shares)

11,183

Face Value (₹)

2

52-Week High (₹)

1,638.35

52-Week High Date

12-Sep-2024

52-Week Low (₹)

725.00

52-Week Low Date

02-Nov-2023

All Time High (₹)

1,638.35

All Time High Date

12-Sep-2024

All Time Low (₹)

1.60

All Time Low Date

17-Sep-2001

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). The Company's focus is primarily on niche therapeutic areas and complex products. It sells products in over 40 countries. FDF products are sold in the United States India Europe and the rest of the world (RoW). Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil Europe and USA. In the API segment Natco has capabilities to develop and manufacture products ...
Read More

Natco Pharma News

Natco Pharma shares hit all time high, extend gain for second day; details

2 min read

Natco Pharma stock rises 3% after subsidiary invests $8 mn in biotech firm

3 min read

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

3 min read

Natco Pharma stock surges 8%, hits new 52-week high on strong Q4 show

2 min read

Q4 results today: LIC, NMDC, AstraZeneca among 303 firms to post earnings

6 min read

USFDA pulls up Natco Pharma for several violations at Telangana plant

2 min read
More

Natco Pharma Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

27,970

EPS - TTM (₹) [C]

91.37

P/E Ratio (X) [C]

17.09

Face Value (₹) 2
Latest Dividend (%)150.00
Latest Dividend Date 23-Aug-2024
Dividend Yield (%) 0.60
Book Value Share (₹) [C]326.79
P/B Ratio (₹) [C]4.78

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Tata Equity P/E Fund - (G) 224.17 14,58,000 2.48
Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 224.17 14,58,000 2.48
Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5%) 224.17 14,58,000 2.48
Tata Equity P/E Fund - Direct (G) 224.17 14,58,000 2.48
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt A-5%) 224.17 14,58,000 2.48
Tata Equity P/E Fund - Dir(IDCW-Trigger-Opt B-10%) 224.17 14,58,000 2.48
SBI Magnum Midcap Fund (G) 115.40 7,50,551 0.54
SBI Magnum Midcap Fund (IDCW) 115.40 7,50,551 0.54
SBI Magnum Midcap Fund - Direct (G) 115.40 7,50,551 0.54
SBI Magnum Midcap Fund - Direct (IDCW) 115.40 7,50,551 0.54

Load more

Research Reports

DateBrokerActionPrices(₹) Report
16-Feb-2023ICICI Direct Hold 565

Stock Strength

Today's Low/High (₹)

1,558.15

1,583.10

Week Low/High (₹)

1,535.20

1,639.00

Month Low/High (₹)

1,425.00

1,639.00

Year Low/High (₹)

724.20

1,639.00

All time Low/High (₹)

1.60

1,639.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week1.05%1.04%1.411.51%
1 Month6.71%6.82%3.293.58%
3 Month29.04%29.00%7.918.32%
6 Month63.33%63.41%14.3715.42%
1 Year76.48%77.01%22.4725.88%
3 Year65.75%66.60%40.7844.55%

Company Info

Company Information

Chairman & Managing Director : V C Nannapaneni

Vice Chairman & CEO : Rajeev Nannapaneni

Vice President & Director : PSRK Prasad

President & Director : D Linga Rao

Vice President & Director : Pavan Bhat

Company Sec. & Compli. Officer : Venkat Ramesh

Independent Director : A D Murthy Chavali

Independent Director : B. Lakshminarayana

Independent Director : Kantipudi Suma

Independent Director : Nitin Jain

Independent Director : Vijayabhaskar Dronadula

Registered Office: Natco House, Road No 2 Banjara Hills,Hyderabad,Telangana-500033 Ph: 91-040-23547532

Email:investors@natcopharma.co.in

URL:http://www.natcopharma.co.in

FAQs about Natco Pharma Ltd

1. What's the Natco Pharma Ltd share price today?
Natco Pharma Ltd share price was Rs 1,561.90 at 04:01 PM IST on 17th Sep 2024. Natco Pharma Ltd share price was down by 0.02% from the previous closing price of Rs 1,562.20. Natco Pharma Ltd share price trend:

  • Last 1 Month: Natco Pharma Ltd share price moved up by 6.71% on BSE
  • Last 3 Months: Natco Pharma Ltd share price moved up by 29.04% on BSE
  • Last 12 Months: Natco Pharma Ltd share price moved up by 76.48% on BSE
  • Last 3 Years: Natco Pharma Ltd price moved up by 65.75% on BSE


2. How can I quickly analyse the performance of the Natco Pharma Ltd stock?
The performance of the Natco Pharma Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 17.09
  • Price to book value ratio is 4.78
  • Dividend yield of 0.60
  • The EPS (trailing 12 months) of the Natco Pharma Ltd stock is Rs 91.37


3. What is the market cap of Natco Pharma Ltd?
Natco Pharma Ltd has a market capitalisation of Rs 27,974 crore.


4. What is Natco Pharma Ltd's 52-week high/low share price?
The Natco Pharma Ltd’s 52-week high share price is Rs 1,638.35 and 52-week low share price is Rs 725.00.


5. Is the Natco Pharma Ltd profitable?
On a consolidated basis, Natco Pharma Ltd reported a profit of Rs 636.30 crore on a total income of Rs 1,276.70 crore for the quarter ended 2024. For the year ended Jun 2024, Natco Pharma Ltd had posted a profit of Rs 668.50 crore on a total income of Rs 1,410.70 crore.


6. Which are Natco Pharma Ltd’s peers in the Health care sector?
Natco Pharma Ltd’s top 5 peers in the Health care sector are Suven Pharma, J B Chemicals &, Emcure Pharma, Natco Pharma, Pfizer, Laurus Labs, Alembic Pharma.


7. Who owns how much in Natco Pharma Ltd?
Key changes to the Natco Pharma Ltd shareholding are as follows:

  • Promoter holding in Natco Pharma Ltd has gone up to 49.71 per cent as of Jun 2024 from 49.71 per cent as of Sep 2023.